昭衍新药股价跌5.02%,华宝基金旗下1只基金位居十大流通股东,持有1465.31万股浮亏损失3106.46万元

新浪财经
Sep 17

9月17日,昭衍新药跌5.02%,截至发稿,报40.08元/股,成交15.80亿元,换手率6.16%,总市值300.39亿元。资料显示,北京昭衍新药研究中心股份有限公司位于北京市经济技术开发区荣京东街甲5号,香港铜锣湾希慎道33号利园1期19楼1920室,成立日期1998年2月25日,上市日期2017年8月25日,公司主营业务涉及以药物非临床安全性评价服务为主的药物临床前研究服务和实验动物及附属...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10